Associate Director, Omnichannel Content Strategy & Operations

Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.

Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.

The Opportunity:

The Portfolio Omnichannel Strategy & Operations Team is seeking an experienced omnichannel marketing content operations leader to support commercial customer engagement across the Revolution Medicines oncology portfolio. This newly created role will establish and scale content lifecycle planning, modular content operations, content taxonomy, content governance, and omnichannel content review, approval and activation processes across brands, tumor types, indications, and customer audiences.

The Associate Director, Omnichannel Content Strategy & Operations will serve as the US Portfolio Omnichannel team's subject matter expert for content strategy, content supply operations, and omnichannel content activation. This individual will partner closely with Marketing, Portfolio Omnichannel Leads, Medical, Legal, Regulatory (MLR), Analytics & Insights, IS/IT, and agency partners to ensure content is designed, approved, managed, and deployed efficiently across personal and non-personal channels. This role will own the commercial digital asset management (DAM) strategy and operating model, including asset lifecycle management, discoverability, reuse, and platform business requirements in partnership with IS/IT. The role will also own content taxonomy strategy and governance, establishing a consistent classification and metadata framework across brands, tumor types, indications, audiences, and channels.

The role will be responsible for translating brand strategy, customer journeys, and engagement objectives into scalable content plans and modular content frameworks that enable personalized customer experiences across email, websites, CRM, paid media, social media, field-triggered communications, congress activities, and future orchestration capabilities. This position will establish consistent content operations, governance standards, review processes, and measurement approaches to improve speed-to-market, reuse, compliance, and customer relevance. This role will also help shape the future state content ecosystem required to support launches, in-line brands, and evolving omnichannel capabilities.

Working in a matrixed environment, the Associate Director will collaborate closely with the Portfolio Omnichannel Tumor leads and Brand Marketing leads, who retain ownership of overall engagement strategy and business priorities. This individual will provide strategic leadership for content systems, workflows, modular content design, and omnichannel content activation while driving operational excellence across brands and customer segments.

The Associate Director, Omnichannel Content Strategy & Operations will also be the business owner for any content management related processes or platforms. In this function they will work closely with Commercial IT and A&I data teams to enable planned programs, projects, initiatives and measurement to efficiently and effectively be inculcated across the US Revolution Medicines Commercial business. This role will also liase with similar ex-US capability teams and roles as needed for strategic programs, lessons learned and innovation opportunities.

This role is effectively le